The aim of this five arm randomized trial was thus to compare selective serotonin reuptake
inhibitor (SSRI)sertraline and citalopram to a dual reuptake inhibitor venlafaxine, a
nor-adrenaline reuptake inhibitor reboxetine and a control group receiving placebo, with the
primary endpoint being bone mineral density, and secondary endpoints being bone turnover
markers.